UNFO Introduces Innovative Corrective Foot Brace for Newborns
Israeli Doctor Revolutionizes Treatment for Metatarsus Adductus (MTA) in Newborns, Replacing the Need for Casting And Surgical Intervention
UNFO is gaining recognition across leading medical and healthcare publications worldwide.
Explore how our approach to early, non-invasive treatment is shaping the conversation around infant foot development and care.
Israeli Doctor Revolutionizes Treatment for Metatarsus Adductus (MTA) in Newborns, Replacing the Need for Casting And Surgical Intervention
Israeli Doctor Revolutionizes Treatment for Metatarsus Adductus (MTA) in Newborns, Replacing the Need for Casting And Surgical Intervention
Israeli Doctor Revolutionizes Treatment for Metatarsus Adductus (MTA) in Newborns, Replacing the Need for Casting And Surgical Intervention
UNFO Med Ltd., the manufacturer of the Universal Neonatal Foot Orthotics (UNFO) system, is thrilled to introduce a first of its kind corrective foot brace for the treatment of various foot conditions such as Metatarsus Adductus (MTA), a common condition in newborns that causes the front half of the foot, or forefoot, to turn inward.
UNFO Med Ltd., the manufacturer of the Universal Neonatal Foot Orthotics (UNFO) system, is thrilled to introduce a first of its kind corrective foot brace for the treatment of various foot conditions such as Metatarsus Adductus (MTA), a common condition in newborns that causes the front half of the foot, or forefoot, to turn inward.
UNFO Med Ltd., the manufacturer of the Universal Neonatal Foot Orthotics (UNFO) system, is thrilled to introduce a first of its kind corrective foot brace for the treatment of various foot conditions such as Metatarsus Adductus (MTA), a common condition in newborns that causes the front half of the foot, or forefoot, to turn inward.
A discussion and explanation of metatarsus adductus, why screening is important, and the UNFO brace for treatment.
From beneath a warm swaddling of blankets, Marisa Fine had no way of knowing that her newborn son had a foot deformity. But about 2 weeks after he was born, something looked odd during bath time.
[TEL AVIV, July 30, 2026] – UNFO Med Ltd., manufacturer of the Universal Neonatal Foot Orthotics (UNFO) system, today announced its partnership with OrthoPediatrics to bring its FDA-registered corrective foot brace for Metatarsus Adductus (MTA) to the United States. The condition affects approximately 5% of newborns, causing the front of the foot to turn inward. UNFO marks the first non-invasive alternative to casting and surgery for this condition.
Israeli Doctor Revolutionizes Treatment for Metatarsus Adductus (MTA) in Newborns, Replacing the Need for Casting And Surgical Intervention
Partnership Delivers First Alternative to Painful Casting for Metatarsus Adductus, Affecting Hundreds of Thousands of Newborns Annually
Join the growing number of parents and professionals choosing UNFO for early intervention. Designed for comfort, built for results, and trusted worldwide.
Explore UNFO >